Innovation Medical Research Center | Miami, FL logo

Innovation Medical Research Center | Miami, FL

Research site
9299 SW 152 Street, Suite 205, Miami, Florida, United States of America
Site insights

Top conditions

Human Influenza (6 trials)

Non-alcoholic Fatty Liver Disease (4 trials)

Fatty Liver (4 trials)

Polycystic Kidney Diseases (3 trials)

Autosomal Dominant Polycystic Kidney (3 trials)

Top treatments

Bardoxolone Methyl
Tc 99m

Data sourced from

Contact this site

Albert Garcia

Verified by this site


13 of 33
Status: Active
Trial type: Interventional
Funder type: Industry

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

The co-primary objectives of the study are to:Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Validated Invest...

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
Biological: mRNA-1273.222
Biological: mRNA-1283.222

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

This protocol includes 2 standalone studies with randomization, data collection, analysis and reporting conducted independently.The main objectives o...

Active, not recruiting
Drug: Placebo
Drug: Upadacitinib

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vaccine is compared to...

Biological: Placebo
Biological: Influenza and COVID-19 Combination B

This study will establish a normative database of Tilmanocept Uptake Values (TUVjoint) in healthy controls age-matched to the RA population.

Active, not recruiting
Rheumatoid Arthritis
Drug: Tc99m tilmanocept

This Phase 2 Extension trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine...

Drug: ABP-450

This Phase 2 trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per m...

Active, not recruiting
Drug: ABP-450
Drug: Placebo

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenz...

Active, not recruiting
Seasonal Influenza
Biological: Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
Biological: mRNA-1010

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Irritable Bowel Syndrome With Diarrhea
Drug: CIN-103
Drug: Placebo

Primary Objective:Primary population (former smokers cohort):Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acut...

Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab SAR440340

Trial sponsors

Moderna logo

Moderna (3 trials)


AEON Biopharma (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems